津药药业 (600488.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(津药药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 771,230,226.31937,214,652.51863,769,688.70945,047,972.28814,519,792.251,032,718,648.68990,540,207.94
 营业收入(元) 771,230,226.31937,214,652.51863,769,688.70945,047,972.28814,519,792.251,032,718,648.68990,540,207.94
二、营业总成本(元) 711,516,684.12809,444,384.31759,000,837.68996,501,769.64772,670,074.50954,499,564.38866,504,739.66
 营业成本(元) 460,567,317.92493,361,326.14475,513,886.07576,237,813.93454,806,412.39545,301,569.14450,297,284.75
 研发费用(元) 51,970,851.1544,871,485.4738,968,129.6136,222,007.4439,976,752.4538,194,673.1946,733,026.35
 营业税金及附加(元) 9,996,689.1410,186,213.979,997,202.7811,631,918.4611,202,409.9013,661,166.4112,033,285.51
 销售费用(元) 95,761,345.36183,665,479.01155,819,677.30275,723,198.22192,077,001.08299,383,084.42283,724,312.31
 管理费用(元) 87,525,786.0377,617,930.0075,241,100.3891,022,394.3369,736,468.1163,887,100.3561,113,345.33
 财务费用(元) 5,694,694.52-258,050.283,460,841.545,664,437.264,871,030.57-5,928,029.1312,603,485.41
  其中:利息费用(元) 7,050,791.287,331,767.998,463,756.687,626,908.737,635,142.198,840,732.0412,579,342.77
  其中:利息收入(元) 2,150,496.241,937,892.662,171,262.932,190,288.171,270,296.602,477,059.452,634,582.80
 资产减值损失(元) -2,875,716.35-20,993,783.60-32,754,169.06-14,376,800.71-2,591,831.65-10,101,590.93-30,155,342.70
 信用减值损失(元) -93,104.83229,676.71-322,968.89221,781.785,727.4766,205.46-266,843.30
三、其他经营收益
 加:公允价值变动收益(元) ------653,000.00128,000.00
 加:投资收益(元) -1,468,306.13254,576.97786,063.72-406,033.56-132,766.282,093,763.04-2,680,986.66
  其中:对联营企业和合营企业的投资收益(元) -1,468,306.13254,576.97782,371.14-369,233.56392,233.722,342,108.14-2,631,131.76
 资产处置收益(元) -217,403.31------
 其他收益(元) 5,697,949.497,405,254.205,721,865.9722,741,519.972,978,624.026,113,034.302,596,270.90
四、营业利润(元) 60,756,961.06114,471,507.5278,199,642.76-42,621,452.7942,634,471.3175,737,496.1793,656,566.52
 加:营业外收入(元) 319,680.44445,096.711,430,686.98274,384.93358,704.80247,598.12434,876.71
 减:营业外支出(元) 27,826.08203,166.4513,107.18588,969.99439,674.591,092,343.12361,835.91
五、利润总额(元) 61,048,815.42114,713,437.7879,617,222.56-42,936,037.8542,553,501.5274,892,751.1793,729,607.32
 减:所得税费用(元) -417,350.889,792,933.657,134,716.48-11,641,720.573,907,357.686,256,259.947,044,821.16
六、净利润(元) 61,466,166.30104,920,504.1372,482,506.08-31,294,317.2938,646,143.8568,636,491.2386,684,786.16
(一)按经营持续性分类
  持续经营净利润(元) 61,466,166.30104,920,504.1372,482,506.08-31,294,317.2938,646,143.8568,636,491.2386,684,786.16
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 44,675,140.1584,008,230.3658,012,016.03-34,696,686.5528,343,847.9855,925,937.1767,479,421.90
  少数股东损益(元) 16,791,026.1520,912,273.7714,470,490.053,402,369.2610,302,295.8712,710,554.0619,205,364.26
 扣除非经常性损益后的净利润(元) 43,960,331.6183,023,751.1256,566,744.03-36,965,560.2026,188,069.0252,375,547.9165,625,537.56
七、每股收益
 一、基本每股收益(元) 0.040.080.05-0.030.030.050.06
 二、稀释每股收益(元) 0.040.080.05-0.030.030.050.06
八、其他综合收益(元) 45,784.601,821,550.68883,439.22-128,869,971.751,376,386.265,445,941.35728,877.24
 归属于母公司股东的其他综合收益(元) 45,784.601,821,550.68883,439.22-128,869,971.751,376,386.265,445,941.35728,877.24
九、综合收益总额(元) 61,511,950.90106,742,054.8173,365,945.30-160,164,289.0440,022,530.1174,082,432.5887,413,663.40
 归属于母公司所有者的综合收益总额(元) 44,720,924.7585,829,781.0458,895,455.25-163,566,658.3029,720,234.2461,371,878.5268,208,299.14
 归属于少数股东的综合收益总额(元) 16,791,026.1520,912,273.7714,470,490.053,402,369.2610,302,295.8712,710,554.0619,205,364.26
公告日期 2024-10-302024-08-292024-04-272024-03-292023-10-282023-08-302023-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院